Nov 13, 2019 / 03:45PM GMT
Jacob K. Johnson - Stephens Inc., Research Division - Analyst
All right. We'll go through my introduction, again. I'm Jacob Johnson, one of the healthcare analysts here at Stephens. Next up, joining us is Bio-Techne, a diversified life science tools company with a portfolio that includes reagents, instruments and services for research and clinical diagnostic markets worldwide. Joining us today are CFO, Jim Hippel; and Senior Director of IR and Corporate Development, Dave Clair. Thank you, guys, for joining us. Maybe to kick things off, Jim or Dave, if you just want to spend a couple of minutes running through the Bio-Techne story, and then we'll launch into Q&A.
James T. Hippel - Bio-Techne Corporation - Senior VP of Finance & CFO
Sure. I'll try to -- I'll do just it relatively briefly. Several in the room here, who I spoke to, know our story already. But our core is that we are a 40-year-old plus business that was one of the first companies, if not the first companies, to manufacture proteins for life science research. And in doing so over the last 40
Bio-Techne Corp at Stephens Investor Conference Transcript
Nov 13, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers